We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.00 | 0.79% | 1,653.50 | 1,653.00 | 1,653.50 | 1,653.50 | 1,634.00 | 1,638.50 | 1,637,510 | 16:09:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.76 | 67.79B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2017 07:18 | Anybody alive???ViiV results in. | phatprofit | |
13/2/2017 09:02 | 13th feb Jefferies buy tp 1780p 10th feb JP Morgan neutral tp 1670p up from 1600p | philanderer | |
11/2/2017 09:46 | Great. Thanks for posts. | philo124 | |
11/2/2017 07:43 | GSK ex div (again) in under 2 weeks ...... ;0) | tradermichael | |
10/2/2017 15:51 | The pull back was a bear trap, soon we can break 1615p and head for 1700p | ny boy | |
10/2/2017 11:02 | Yep, that`s what it was... " UK Industrial Production Growth Tops Expectations " | philanderer | |
10/2/2017 10:45 | Hmm could be pound related then. | tim 3 | |
10/2/2017 09:55 | Did they cut BATS too as the share price trace was pretty much identical to GSK | andyadvfn1 | |
10/2/2017 09:48 | See above cut came out at 9.10. | tim 3 | |
10/2/2017 09:47 | andy, I think Trump said something in his sleep about pharma's being the next on the list after he has finished with the appeals court judges. | solomon | |
10/2/2017 09:45 | After a nice rise this morning why the sudden reversal...pound related ? | andyadvfn1 | |
10/2/2017 09:35 | Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1720p (from 1800p). Story provided by StockMarketWire.com | tim 3 | |
10/2/2017 08:37 | Usually get that when approaching a market top, buyer exhaustion philanderer. GSK will be a defensive play when markets turn south. Happy holding and collecting a nice divi, I think 6%+! | ny boy | |
09/2/2017 10:22 | The bond proxy stocks had a nice few days with yields suggesting inflationary expectations are muted, big move on the UK 10-Year over the last week. May also explain why real estate is getting some support. | essentialinvestor | |
09/2/2017 10:17 | Market seems stuck this morning . Just GSK , AZN and MKS moving for me , everything else dead as a dodo | philanderer | |
09/2/2017 09:43 | FWIW reiterations today... 9th feb Deutsche hold tp 1800p 9th feb JP Morgan neutral tp 1600p 9th feb Liberum buy tp 1900p | philanderer | |
09/2/2017 09:08 | Broker upgrade to 1900p. Solid play 5% divi at present ..I've been buying more this morning for the pension fund. | ny boy | |
09/2/2017 08:52 | Very welcome. | essentialinvestor | |
09/2/2017 08:41 | Onwards to 1700p | ny boy | |
08/2/2017 20:34 | GSK needs no medicine despite talk of poor performance | philanderer | |
08/2/2017 17:19 | Very nice recovery, thought we may have got a double dip, the considered reaction was more positive. | essentialinvestor | |
08/2/2017 16:41 | Nice dip buying at support, onwards & upwards | ny boy | |
08/2/2017 16:25 | GlaxoSmithKline chief Witty defends his strategy as he prepares to step down | philanderer | |
08/2/2017 14:21 | FCF looks strong if you strip out the long list of charges, has there been one year in the past 10 where GSK has not paid a hefty legal charge!. ViiV is the absolute standout. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions